Bath & Body Works, Inc. (NYSE: BBWI) saw its stock decline 3.65% to $18.19 by 2:10 p.m. Eastern time on Wednesday, as investors reacted to the company's latest licensed product launch. The Columbus, Ohio-based retailer unveiled a new collection inspired by Disney's Tim Burton's The Nightmare Before Christmas, but the market's response was tepid, reflecting broader concerns about the company's ability to convert seasonal buzz into sustained sales growth.
The launch comes at a critical juncture for the specialty retailer, which has been grappling with declining foot traffic and a challenging consumer environment. In the first quarter, U.S. and Canadian store sales fell by $48 million, or 4.3%, to $1.062 billion, while direct sales slipped 1.5% to $246 million. International and other revenue provided a small offset, rising 9% to $70 million, but total revenue still declined 3.2% year-over-year to $1.378 billion.
Despite the immediate search interest—"Bath and Body Works Nightmare Before Christmas" became a trending Google query shortly after the announcement—analysts caution that attention does not necessarily translate into transactions. The company has attributed the North American sales decline to lower transaction volumes, partially mitigated by higher average spending per customer.
Chief Executive Daniel Heaf has been candid about the company's performance, stating in May that first-quarter results "remain below the standard our brand is capable of delivering." He outlined a "Consumer First Formula" strategy that is expected to gain traction through 2026 and contribute more significantly in 2027. However, the company's full-year guidance suggests limited near-term improvement, with net sales projected to decline between 2.5% and 4.5%.
The reported first-quarter profit figures were boosted by an $88 million interchange-fee settlement, which lifted reported operating income to $231 million. Excluding that one-time gain, adjusted operating income fell 27.8% to $151 million, and adjusted diluted earnings per share dropped to $0.32 from $0.49. The company also faces headwinds from tariffs, which are expected to pressure gross margins by approximately 130 basis points, and it has reduced product offerings by 10% while expanding its presence on Amazon.
Wall Street remains cautious on the stock. According to MarketBeat, 14 of 18 analysts rate BBWI as a hold, with only three buys and one sell. Price targets range from $15 to $26, with a consensus target of $21.93, implying about 20.5% upside from current levels. Recent analyst actions have been mixed: Wells Fargo maintains an overweight rating with a $26 target, while Goldman Sachs downgraded the stock to sell with a $19 target. Jefferies reiterated a hold but raised its target to $23.
The next major catalyst is the company's earnings report, scheduled for August 27. Investors will be watching closely for signs that the licensed collection can drive store traffic and transactions, as well as improvements in adjusted margins. While the Nightmare Before Christmas line may generate short-term excitement, the company's ability to convert that interest into sustainable growth remains uncertain, especially given ongoing consumer weakness and tariff-related cost pressures.
